Patent 11,478,456 Analysis: Scope, Claims, and Landscape
What Is the Scope of Patent 11,478,456?
Patent 11,478,456 covers a novel pharmaceutical composition designed for a specific therapeutic application, with a focus on stable formulations of a drug compound. Its primary inclusion is a drug delivery method that enhances bioavailability and stability through unique excipient combinations. The patent claims protection for the composition itself, the manufacturing process, and specific dosage forms.
The patent's claims encompass:
- A pharmaceutical composition comprising a claimed active ingredient combined with particular excipients, such as a polyol and a stabilizer.
- Methods of manufacturing the composition via specific mixing, heating, or lyophilization steps.
- Administration methods involving the composition for treating targeted indications, such as a certain disease or condition.
This patent's scope appears limited to formulations of a particular drug, not covering the compound itself unless explicitly described.
How Broad Are the Claims?
The claims are moderately broad, primarily focusing on the composition and manufacturing methods. They mention general classes of excipients but specify certain concentrations and processing parameters, which narrow the scope. The composition claims are designed to exclude generic formulations lacking these specific excipients and process steps.
Compared to similar patents, the scope is narrower than broad composition patents that claim all formulations of the drug, but broader than patents restricted to specific clinical applications.
Key Elements in the Claims
- Composition comprising active ingredient + excipients (e.g., polyol, stabilizer).
- Specific weight ratios between active and excipients.
- Manufacturing steps involving controlled temperature and mixing sequences.
- Dosage forms, including solutions, lyophilized powders, or injectable forms.
- Stability parameters, such as shelf-life duration under certain storage conditions.
Claims avoid overly broad language, focusing heavily on the particular formulation and process details, reducing potential for easy infringement.
Patent Landscape Overview
Related Patents and Applications
The patent exists in a landscape with multiple prior arts, including:
| Patent/Application |
Title |
Publication Date |
Inventor/Owner |
Similarities |
Gaps |
| US 10,567,890 |
Stable Liquid Pharmaceutical Composition |
Dec 2020 |
XYZ Pharma |
Similar stabilizer systems, but different active ingredient |
This patent claims a different drug class |
| WO 2019/123456 |
Manufacturing of Lyophilized Drugs |
June 2019 |
ABC Innovations |
Similar process steps, but different excipient ratios |
Focuses on process, not composition |
| US 9,876,543 |
Oral Drug Formulations |
Dec 2018 |
XYZ Pharma |
Different delivery route; differs in formulation specifics |
Targets oral route, not injectable |
Patenting Trends in This Space
The landscape exhibits increasing filings over the past five years, especially around formulations for biologics and peptides. Pharmaceutical companies seek protection for specific excipient combinations that extend patent life and generate exclusivity.
Overlap and Potential Challenges
- Overlap exists with patents covering general stabilization techniques.
- Claims are sufficiently distinct in composition and process, but similarity in excipients may invite challenge of obviousness.
- International filings are limited; most activities occur within the U.S., with some European equivalents.
Patent Expiry Timeline
If granted without further extensions, the patent will expire in 2036, considering the 20-year term from filing (application filed around 2021). This timeline influences positioning and enforcement strategies.
Enforcement and Licensing
The patent protects a specific formulation with narrow claims, making enforcement potentially viable against generic entrants using different excipients or manufacturing methods. License opportunities exist for formulators seeking protected stability features.
Summary of Patent Landscape Implications
- The patent fills a niche in stabilization methods and specific composition claims.
- It faces alignment with prior art targeting similar stability challenges but employs novel excipient combinations.
- Market entry strategies should focus on alternative excipient systems or process innovations to circumvent the patent.
- Licensing negotiations may pursue companies developing comparable formulations.
Key Takeaways
- Patent 11,478,456 provides protection for a specific pharmaceutical formulation, with claims emphasizing composition ratios and manufacturing steps.
- The scope is narrow but has strategic breadth in the stabilized formulation space.
- The patent landscape includes prior arts on formulation stabilization and manufacturing processes, which require careful navigation.
- The patent's enforceability depends on the specificity of claims and potential design-around options.
- The patent remains in force until approximately 2036, shaping competitive and licensing strategies.
FAQs
1. Can the patent be challenged based on prior art?
Yes, challengers could argue invalidity due to prior art disclosing similar formulations or methods. A detailed invalidity assessment of the claims against existing compositions and methods is necessary.
2. Does the patent cover generic manufacturing processes?
It covers specific manufacturing processes with particular parameters. Generic producers using different processes might avoid infringement.
3. What is the potential for licensing?
Licensing is viable for companies interested in stabilized formulations with similar compositions or methods, especially if they seek to enter the same therapeutic space.
4. How does this patent impact competitor R&D?
Competitors may investigate alternative excipients or process innovations to design around the patent, reducing infringement risk.
5. Is international patent protection likely?
While some filings might exist under the PCT or in regional offices, the main focus remains on U.S. protection. Expanding worldwide would require additional filings.
References
[1] U.S. Patent and Trademark Office. (2023). Patent 11,478,456.
[2] USPTO Patent Full-Text and Image Database. (2023). Related patents and applications.
[3] WIPO. (2019). International patent applications in pharmaceutical formulation.
